The neuropharmacology of yawning

European Journal of Pharmacology

Volumn 343, Issue 1, 1998, Pages 1-16

  Argiolas, Antonio ^a   Melis, Maria Rosaria ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

(Rat); 5 HT (5 hydroxytryptamine, serotonin); Acetylcholine; ACTH MSH peptide; Dopamine; Excitatory amino acid; GABA; Luteinizing hormone releasing hormone (LH RH); Neurotensin; Nitric oxide (NO); Noradrenaline; Opioid peptide; Oxytocin; Paraventricular nucleus of the hypothalamus; Yawning

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR; CORTICOTROPIN; DOPAMINE RECEPTOR; EXCITATORY AMINO ACID RECEPTOR; GONADORELIN; NEUROPEPTIDE; OPIATE PEPTIDE; OXYTOCIN; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; DOPAMINE BRAIN LEVEL; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SEROTONIN BLOOD LEVEL; YAWNING;

AMINO ACID SEQUENCE; ANIMALS; BRAIN; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEUROTRANSMITTER AGENTS; PENILE ERECTION; REFLEX, STRETCH; YAWNING;

EID: 0032484949     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01538-0     Document Type: Review

References (138)

1. Amir, S., 1995. Nitric oxide signalling in the hypothalamus. In: Vincent, S. (Ed.), Nitric Oxide in the Nervous System. Academic Press, London, pp. 151-162.
2. Argiolas A., Gessa G.L. Central functions of oxytocin. Neurosci. Biobehav. Rev. 15:1991;217-231.
3. Argiolas A., Melis M.R., Gessa G.L. Oxytocin: An extremely potent inducer of penile erection and yawning in male rats. Eur. J. Pharmacol. 130:1986;265-272.
4. Argiolas A., Melis M.R., Fratta W., Mauri A., Gessa G.L. Monosodium glutamate does not alter ACTH- or apomorphine-induced penile erection and yawning. Pharmacol. Biochem. Behav. 26:1987;503-507.
5. Argiolas A., Melis M.R., Mauri A., Gessa G.L. Paraventricular nucleus lesion prevents yawning and penile erection induced by apomorphine and oxytocin, but not by ACTH in rats. Brain Res. 421:1987;349-352.
6. 8-vasotocin, a potent oxytocin antagonist, antagonizes penile erection and yawning induced by oxytocin and apomorphine, but not by ACTH-(1-24). Eur. J. Pharmacol. 134:1987;221-224.
7. Argiolas A., Melis M.R., Gessa G.L. Calcium channel inhibitors prevent apomorphine- and oxytocin-induced penile erection and yawning in male rats. Eur. J. Pharmacol. 166:1989;515-518.
8. Argiolas A., Melis M.R., Mauri A., Gessa G.L. Oxytocin-induced penile erection and yawning in male rats: Effect of neonatal monosodium glutamate and hypophysectomy. Psychopharmacology. 97:1989;383-387.
9. Argiolas A., Melis M.R., Stancampiano R., Gessa G.L. Penile erection and yawning induced by oxytocin and related peptides: Structure-activity relationship. Peptides. 10:1989;559-563.
10. Argiolas A., Melis M.R., Stancampiano R., Gessa G.L. Oxytocin-induced penile erection and yawning: Role of calcium and prostaglandins. Pharmacol. Biochem. Behav. 35:1989;601-605.
11. Argiolas A., Melis M.R., Stancampiano R., Gessa G.L. Omega-Conotoxin prevents apomorphine- and oxytocin-induced penile erection and yawning in male rats. Pharmacol. Biochem. Behav. 37:1990;253-257.
12. Argiolas A., Melis M.R., Stancampiano R., Gessa G.L. Role of calcium in the expression of ACTH-induced stretching, yawning and penile erection. Brain Res. Bull. 24:1990;853-856.
13. 1c receptors induce oxytocin release in the male rat. Brain Res. 611:1993;330-332.
14. 2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations. Eur. J. Pharmacol. 229:1992;9-14.
15. Baggio G., Ferrari F. The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats. Psychopharmacology. 80:1983;38-42.
16. Baldessarini, R.J., 1996. Drugs and the treatment of psychiatric disorders. Psychosis and anxiety. In: Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., Gilman, A.G. (Eds.), The Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. McGraw Hill, New York, pp. 399-430.
17. Baraldi G., Ferrari F. Clonidine, DPI, phentolamine and DR-71 antagonism towards N-n-propyl-norapomorphine-produced behavioral effects in rats. Riv. Pharmacol. Ter. 6:1980;173-180.
18. Barbizet J. Yawning. J. Neurol. Neurosurg. Psychiatry. 21:1958;203-209.
19. 1B receptor mediation. Eur. J. Pharmacol. 135:1987;279-287.
20. Berendsen H.H.G., Gower A.J. Opiate-androgen interaction in drug-induced yawning and penile erection in the rat. Neuroendocrinology. 45:1986;185-190.
21. 1C-receptors in drug-induced penile erections in rats. Psychopharmacology. 101:1990;57-61.
22. Bertolini A., Gessa G.L. Behavioural effects of ACTH and MSH peptides. J. Endocrinol. Inv. 4:1981;241-251.
23. Bertolini A., Genedani S., Castelli M. Behavioral effects of naloxone in rats. Experientia. 34:1978;771-772.
24. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA. 87:1990;682-685.
25. Bredt D.S., Hwang P.M., Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:1990;768-770.
26. Buijs R.M., Geffard M., Pool C.W., Hoorneman E.M.D. The dopaminergic innervation of the supraoptic and paraventricular nucleus. A light and electron microscopical study. Brain Res. 323:1984;65-74.
27. Chhajlani V., Wikberg J.E.S. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309:1992;417-420.
28. Di Chiara G., Porceddu M.L., Vargiu L., Argiolas A., Gessa G.L. Evidence for dopamine receptors mediating sedation in the mouse brain. Nature. 264:1976;564-567.
29. Doger E., Urba-Holmgren R., Eguibar J.R., Holmgren B. GABAergic modulation of yawning behavior. Pharmacol. Biochem. Behav. 34:1989;237-240.
30. Dourish C.T., Hutson P.H. Bilateral lesions of the striatum induced with 6-hydroxydopamine abolish apomorphine-induced yawning in rats. Neuropharmacology. 24:1985;1051-1055.
31. Dourish C.T., Cooper S.J., Philips S.R. Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat. Psychopharmacology. 86:1985;175-181.
32. Ferrari W., Gessa G.L., Vargiu L. Behavioural effects induced by intra-cisternally injected ACTH and MSH. Ann. N. Y. Acad. Sci. 104:1963;330-345.
33. Freund-Mercier M.J., Richard P. Excitatory effects of intraventricular injections of oxytocin on the milk ejction reflex in the rat. Neurosci. Lett. 23:1981;193-198.
34. Fujikawa M., Yamada K., Nagashima M., Furukawa T. Involvement of β-adrenoceptors in regulation of the yawning response induced by neuropeptides, oxytocin and α-melanocyte-stimulating hormone, in rats. Pharmacol. Biochem. Behav. 50:1995;339-343.
35. 1-receptor agonist YM796 evokes yawning and increases oxytocin secretion from the posterior pituitary gland in rats. Pharmacol. Biochem. Behav. 55:1996;55-60.
36. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., Del Valle J., Yamada T. Molecular cloning expression and gene localization of a fourth melanotropin receptor. J. Biol. Chem. 268:1993;15174-15179.
37. Gessa G.L., Pisano M., Vargiu L., Crabai F., Ferrari W. Stretching and yawning movements after intracerebral injection of ACTH. Rev. Can. Biol. 26:1967;2229-2236.
38. Gispen W.H., Wiegant V.M., Greven H.M., De Wied D. The induction of excessive grooming in the rat by intraventricular application of peptides derived from ACTH: Structure-activity studies. Life Sci. 17:1975;645-652.
39. Gower A.J. Effects of acetylcholine agonists and antagonists on yawning and analgesia in the rat. Eur. J. Pharmacol. 139:1987;79-89.
40. Gower A.J., Berendsen H.H.G., Broekkamp C.L. Antagonism of drug-induced yawning and penile erection. Eur. J. Pharmacol. 122:1986;239-244.
41. Hawthorn J., Ang V.T., Jenkins J.S. Effects of lesions in the hypothalamic paraventricular, supraoptic and suprachiasmatic nuclei on vasopressin and oxytocin in rat brain and spinal cord. Brain Res. 346:1985;51-57.
42. Holmgren B., Urba-Holmgren R., Trucios N., Zermeno M., Eguibar J.R. Association of spontaneous and dopaminergic-induced yawning and penile erections in the rat. Pharmacol. Biochem. Behav. 22:1985;31-35.
43. Holmgren B., Budelli R., Urba-Holmgren R., Eguibar J.R., Holmgren M., Baz-Tellez G., Anias J. Food anticipatory yawning rhythm in the rat. Acta Neurobiol. Exp. 51:1991;97-105.
44. Humprey P.P.A., Hartig P., Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 14:1993;233-236.
45. Ignarro L.J. Biosynthesis and metabolism of endothelium derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30:1990;535-560.
46. Jurko M.F., Andy O.J. Post-lesion yawning and thalatomy site. Appl. Neurophysiol. 38:1975;73-79.
47. Kebabian J.W., Calne D.B. Multiple receptors for dopamine. Nature. 277:1982;3-96.
48. Kimura H., Yamada K., Nagashima M., Furukawa T. Involvement of catecholamine receptor activities in modulating the incidence of yawning in rats. Pharmacol. Biochem. Behav. 53:1996;1017-1021.
49. Lal S., Tesfaye Y., Thavundayil J.X., Thompson T.R., Kiely M.E., Vasavan Nair N.P., Grassino A., Dubrovski B. Apomorphine: Clinical studies on erectile impotence and yawning. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 13:1989;329-339.
50. 2+ concentration of isolated rat supraoptic cells in response to oxytocin. J. Physiol. (London). 478:1994;275-288.
51. Lang R.E., Heil J., Ganten D., Herman K., Rascher W., Unger Th. Effect of lesions in the paraventricular nucleus of the hypothalamus on vasopressin and oxytocin content in the brainstem and spinal cord of rat. Brain Res. 260:1983;326-329.
52. Laping N.J., Ramirez V.D. Prolactin induces yawning and the stretch-yawning syndrome in young adult male rats. Horm. Behav. 20:1986;49-59.
53. Laping N.J., Ramirez V.D. Prolactin-induced yawning behavior requires an intact nigrostriatal dopamine system. Pharmacol. Biochem. Behav. 29:1988;59-62.
54. Lehmann H.E. Yawning: A homeostatic reflex and its psychological significance. Bull. Menninger Clinic. 43:1979;123-136.
55. Lindvall O., Björklund A. Anatomy of dopaminergic neurons. Adv. Psychopharmacol. 19:1978;1-23.
56. Lindvall O., Björklund A., Skagerberg G. Selective histochemical demonstration of dopamine terminal systems in rat di- and telencephalon: New evidence for dopaminergic innervation of hypothalamic neurosecretory nuclei. Brain Res. 306:1984;19-30.
57. Luo D., Knezevich S., Vincent S.R. N-Methyl-D-aspartate-induced nitric oxide release: An in vivo microdialysis study. Neuroscience. 57:1993;897-900.
58. Maeda N., Matsuoka N., Yamaguchi I. Septohippocampal cholinergic pathway and penile erections induced by dopaminergic and cholinergic stimulants. Brain Res. 537:1990;163-168.
59. Melis M.R., Argiolas A. Nitric oxide synthase inhibitors prevent apomorphine- and oxytocin-induced penile erection and yawning in male rats. Brain Res. Bull. 32:1993;71-74.
60. Melis M.R., Argiolas A. Nitric oxide donors induce penile erection and yawning when injected in the central nervous system of male rats: Mechanism of action. Eur. J. Pharmacol. 294:1995;1-9.
61. Melis M.R., Argiolas A. Role of central nitric oxide in the control of penile erection and yawning. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 21:1997;899-922.
62. Melis M.R., Argiolas A., Gessa G. L Oxytocin-induced penile erection and yawning: Site of action in the brain. Brain Res. 396:1986;259-265.
63. Melis M.R., Argiolas A., Gessa G.L. Apomorphine-induced penile erection and yawning: Site of action in brain. Brain Res. 415:1987;98-104.
64. Melis M.R., Argiolas A., Gessa G.L. Evidence that apomorphine induces penile erection and yawning by releasing oxytocin in the central nervous system. Eur. J. Pharmacol. 164:1989;565-572.
65. Melis M.R., Argiolas A., Stancampiano R., Gessa G.L. Effect of apomorphine on oxytocin concentrations in different brain areas and plasma of male rats. Eur. J. Pharmacol. 182:1990;101-107.
66. Melis M.R., Stancampiano R., Argiolas A. Hippocampal oxytocin mediates apomorphine-induced penile erection and yawning. Pharmacol. Biochem. Behav. 42:1992;61-66.
67. Melis M.R., Stancampiano R., Argiolas A. Effect of excitatory aminoacid receptor antagonists on apomorphine-, oxytocin- and ACTH-induced penile erection and yawning in male rats. Eur. J. Pharmacol. 220:1992;43-48.
68. Melis M.R., Stancampiano R., Gessa G.L., Argiolas A. Prevention by morphine of apomorphine- and oxytocin-induced penile erection: Site of action in the brain. Neuropsychopharmacology. 6:1992;17-21.
69. Melis M.R., Mauri A., Argiolas A. Apomorphine- and oxytocin-induced penile erection and yawning in intact and castrated male rats: Effect of sexual steroids. Neuroendocrinology. 59:1994;349-354.
70. Melis M.R., Stancampiano R., Argiolas A. Penile erection and yawning induced by paraventricular NMDA injection in male rats are mediated by oxytocin. Pharmacol. Biochem. Behav. 48:1994;203-207.
71. G-nitro-L-arginine methylester of apomorphine- and oxytocin-induced penile erection and yawning: Site of action in the brain. Pharmacol. Biochem. Behav. 48:1994;799-804.
72. Melis M.R., Stancampiano R., Argiolas A. Nitric oxide synthase inhibitors prevent N-methyl-D-aspartic acid-induced penile erection and yawning in male rats. Neurosci. Lett. 179:1994;9-12.
73. 1c agonists in male rats. Naunyn-Schmiedeberg Arch. Pharmacol. 351:1995;439-446.
74. Melis M.R., Stancampiano R., Lai C., Argiolas A. Nitroglycerin-induced penile erection and yawning in male rats: Mechanism of action in the brain. Brain Res. Bull. 36:1995;527-531.
75. Melis M.R., Succu S., Argiolas A. Dopamine agonists increase nitric oxide production in the paraventricular nucleus of the hypothalamus of male rats: Correlation with penile erection and yawning. Eur. J. Neurosci. 8:1996;2056-2063.
76. Melis M.R., Succu S., Iannucci U., Argiolas A. Oxytocin increases nitric oxide production in the paraventricular nucleus of the hypothalamus of male rats: Correlation with penile erection and yawning. Regul. Pept. 69:1997;105-111.
77. Melis M.R., Succu S., Iannucci U., Argiolas A. Prevention by morphine of apomorphine- and oxytocin-induced penile erection and yawning: Involvement of nitric oxide. Naunyn-Schmiedeberg Arch. Pharmacol. 355:1997;595-600.
78. Melis M.R., Succu S., Iannucci U., Argiolas A. N-Methyl-D-aspartic acid-induced penile erection and yawning: Role of hypothalamic paraventricular nitric oxide. Eur. J. Pharmacol. 328:1997;115-123.
79. Melis M.R., Succu S., Argiolas A. Prevention by morphine of N-methyl-D-aspartic acid-induced penile erection and yawning: Involvement of nitric oxide. Brain Res. Bull. 44:1997;689-694.
80. Mogilnicka E., Klimek V. Drugs affecting dopamine neurons and yawning behavior. Pharmacol. Biochem. Behav. 7:1977;303-305.
81. Mogilnicka E., Bissard C.G., Delini-Stula A. Effects of apomorphine, TL-99 and 3-PPP on yawning in rats. Neuropharmacology. 23:1984;19-22.
82. Monaghan D.T., Bridges R.J., Cotman C.W. The excitatory amino acid receptors: Their classes, pharmacology and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 29:1989;365-398.
83. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:1993;2002-2012.
84. Mora S., Diaz-Veliz G. LH-RH antagonizes yawning and genital grooming induced by apomorphine in rats. Pharmacol. Biochem. Behav. 31:1989;717-720.
85. Morelli M., Longoni R., Spina L., DiChiara G. Antagonism of apomorphine-induced yawning by SCH 23390: Evidence against the dopamine autoreceptor hypothesis. Psychopharmacology. 89:1986;259-260.
86. Moss F., Freund-Mercier M.J., Guernè Y., Guernè M.J., Stoeckel M.E., Richard P. Release of oxytocin and vasopressin by magnocellular nuclei in vitro: Specific facilitatory effect of oxytocin on its own release. J. Endocrinol. 102:1984;63-72.
87. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1992;1248-1251.
88. Muhlethaler M., Gahwiler B.H., Dreifuss J.J. Enkephalin-induced inhibition of hypothalamic paraventricular neurons. Brain Res. 197:1980;264-268.
89. Nouel D., Costentin J. Inhibition of apomorphine-induced yawning and penile erection by neurotensin. Peptides. 12:1991;755-759.
90. O'Brien, C.P., 1996. Drug addiction and drug abuse. In: Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., Gilman, A.G. (Eds.), The Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. McGraw Hill, New York, pp. 557-580.
91. O'Donohue T.L., Dorsa D.M. The opiomelanocortinergic neuronal and endocrine systems. Peptides. 3:1982;353-395.
92. Ohta K., Araki N., Hamada J., Komatsumoto S., Shimazu K., Fukuuchi Y. A novel in vivo assay system for consecutive measurement of brain nitric oxide production combined with the microdialysis technique. Neurosci. Lett. 176:1994;165-168.
93. Okuyama S., Shimamura H., Hasimoto S., Aihara H. Relation between yawning behavior and central serotoninergic neuronal systems in rats. Naunyn-Schmiedebergs Arch. Pharmacol. 335:1987;667-672.
94. Ontjes D.A., Kirk Ways D., Mahaffee D.D., Zimmermann C.F., Gwynne J.T. ACTH receptors and the effect of ACTH on adrenal organelles. Ann. N. Y. Acad. Sci. 297:1977;295-313.
95. Pittman Q.J., Hatton J.D., Bloom F.E. Morphine and opioid peptides reduce paraventricular neuronal activity: Study on the rat hypothalamic slice preparation. Proc. Natl. Acad. Sci. USA. 77:1980;5525-5531.
96. Poggioli R., Vergoni A.V., Guarini S., Bertolini A. Influence of clonidine on the ACTH-induced behavioral syndrome. Eur. J. Pharmacol. 101:1984;299-301.
97. Poggioli R., Vergoni A.V., Giuliani D., Marrama D., Rasori E., Bertolini A. Brain acetylcholine is involved in the ACTH-induced syndrome in rats. Neurosci. Res. Commun. 8:1991;103-110.
98. 2+ channel blockers. J. Endocrinol. Inv. 16:1993;83-96.
99. Poggioli R., Benelli A., Arletti R., Cavazzuti E., Bertolini A. Nitric oxide is involved in the ACTH-induced syndrome. Peptides. 16:1995;1263-1268.
100. Poulain D.A., Wakerly J.B. Electrophysiology of hypothalamic magnocellular neurones secreting oxytocin and vasopressin. Neuroscience. 7:1982;773-808.
101. Price Heusner A. Yawning and associated phenomena. Physiol. Rev. 26:1946;156-168.
102. Protais P., Dubuc I., Costentin J. Pharmacological characterization of dopamine receptors involved in the dual effect of dopamine agonists on yawning behavior in rats. Eur. J. Pharmacol. 94:1983;271-280.
103. Provine R.R. Yawning as a stereotyped action pattern and releasing stimulus. Ethology. 72:1986;109-122.
104. 2 and exercise. Behav. Neural Biol. 48:1987;382-393.
105. Provine R.R., Hamerink H.B., Curchack B.C. Yawning: Relation to sleep and stretching in humans. Ethology. 76:1987;152-160.
106. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Motrud L.T., Low M.J., Tatro J.Em., Entwistle M.L., Simerly R., Cone R.D. Identification of a receptor for gamma-MSH and other proopiomelanocortin peptides in the hypothalamus and limbic systems. Proc. Natl. Acad. Sci. USA. 90:1993;8856-8860.
107. Sanchez F., Alonso J.R., Arevalo R., Blanco E., Aijon J., Vazquez R. Coexistence of NADPH-diaphorase with vasopressin and oxytocin in the hypothalamic magnocellular neurosecretory nuclei of the rat. Cell Tissue Res. 276:1994;31-34.
108. Saydoff J.A., Rittenhouse P.A., Van de Kar L.D., Brownfield M.S. Enhanced serotoninergic transmission stimulates oxytocin secretion in conscious male rats. J. Pharmacol. Exp. Ther. 257:1991;95-99.
109. Schuman E.M., Madison D.V. Nitric oxide and synaptic function. Annu. Rev. Neurosci. 17:1994;153-183.
110. Serra G., Collu M., Loddo S., Celasco G., Gessa G.L. Hypophysectomy prevents yawning and penile erection but not hypomotility induced by apomorphine. Pharmacol. Biochem. Behav. 19:1983;917-919.
111. Serra G., Fratta W., Collu M., Napoli-Farris L., Gessa G.L. Ciclo-heximide prevents apomorphine-induced yawning, penile erection and genital grooming in rats. Eur. J. Pharmacol. 86:1983;279-282.
112. Serra G., Collu M., Serra A., Gessa G.L. Estrogens antagonize apomorphine-induced yawning in rats. Eur. J. Pharmacol. 104:1984;383-386.
113. Serra G., Collu M., Gessa G.L. Dopamine receptors mediating yawning: Are they autoreceptors? Eur. J. Pharmacol. 120:1986;187-192.
114. Serra G., Collu M., Gessa G.L. Yawning is elicited by D2 dopamine agonists, but is blocked by the D1 antagonist SCH 23390. Psychopharmacology. 91:1987;330-333.
115. 1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonists. Psychopharmacology. 108:1992;47-50.
116. Snyder S.H. Nitric oxide: First in a new class of neurotransmitters? Science. 257:1992;494-496.
117. Southam E., Garthwaite J. The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology. 32:1993;1267-1277.
118. Stahle L. Do autoreceptors mediate dopamine-agonist-induced yawning and suppression of exploration? A critical review. Psychopharmacology. 106:1992;1-13.
119. Stahle L., Ungerstedt U. Assessment of dopamine autoreceptor agonist properties of apomorphine, (+)-3-PPP, and (-)-3-PPP by recording of yawning behavior in rats. Eur. J. Pharmacol. 98:1984;307-310.
120. Stancampiano R., Melis M.R., Argiolas A. Apomorphine- and oxytocin-induced penile erection and yawning: Effect of pertussis toxin. Brain Res. Bull. 28:1992;315-318.
121. 1c receptor agonists in male rats: Relationship with dopaminergic and oxytocinergic transmission. Eur. J. Pharmacol. 261:1994;149-155.
122. Stoessl A.J., Dourish C.T., Iversen S.D. Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra. Psychopharmacology. 93:1987;336-342.
123. Stoof J., Kebabian J. Two dopamine receptors: Biochemistry, physiology and pharmacology. Life Sci. 35:1984;2281-2296.
124. Swanson L.W., Swachensko P.E. Hypothalamic integration: Organization of the paraventricular and supraoptic nuclei. Annu. Rev. Neurosci. 6:1983;269-324.
125. Szele F.G., Murphy D.L., Garrick N.A. Effects of fenfluramine, m-chloro-phenylpiperazine and other serotonin related agonists and antagonists on penile erection in nonhuman primates. Life Sci. 43:1988;1297-1304.
126. Torres G., Soon Lee, Rivier C. Ontogeny of the rat hypothalamic nitric oxide synthase and colocalization with neuropeptides. Mol. Cell. Neurosci. 4:1993;155-163.
127. Urba-Holmgren R., Gonzales R.M., Holmgren B. Is yawning a cholinergic response? Nature. 267:1977;261-262.
128. Urba-Holmgren R., Trucios N., Holmgren B., Eguibar J.R., Gavito G., Cruz G., Santos A. Genotypic dependency of spontaneous yawning frequency in the rat. Behav. Brain Res. 40:1990;29-35.
129. Van de Kar L.D. Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annu. Rev. Pharmacol. Toxicol. 31:1991;289-320.
130. Vincent S.R., Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience. 46:1992;755-784.
131. Vischer A.L. Uber das gahen und seine spontanen mitbewegungen. Schweiz. Med. Wschr. 89:1959;1356-1359.
132. Wood P.L., Maithe-Sorenssen D., Cheney D.L., Costa E. Increase of hippocampal acetylcholine turnover rate and the stretching yawning syndrome elicited by alpha-MSH and ACTH. Life Sci. 22:1978;673-678.
133. Wood P.L., Cheney D.L., Costa E. Modulation of the turnover rate of hippocampal acetylcholine by neuropeptides: Possible site of action of α-melanocyte-stimulating hormone and somatostatin. J. Pharmacol. Exp. Ther. 209:1979;97-103.
134. Wuarin J.-P., Dubois-Dauphin M., Raggenbass M., Dreifuss J.J. Effect of opioid peptides on the paraventricular nucleus of the guinea pig hypothalamus is mediated by μ-type receptors. Brain Res. 445:1988;289-296.
135. Yamada K., Furukawa T. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning. Psychopharmacology. 67:1980;39-43.
136. Yamada K., Tanaka M., Shibata K., Furukawa T. Involvement of septal and striatal dopamine D-2 receptors in yawning behavior. Psychopharmacology. 90:1986;9-13.
137. Yamada K., Matsumoto S., Nagashima M., Kumagai M., Kimura H., Furukawa T. Involvement of central β-adrenoceptors in the regulation of the yawning response. Naunyn-Schmiedebergs Arch. Pharmacol. 340:1989;26-30.
138. Zarrindstat M.R., Poursoltan M. Interactions of drugs acting on central dopamine receptors and cholinoreceptors on yawning responses in the rats induced by apomorphine, bromocriptine or physostigmine. Br. J. Pharmacol. 96:1989;843-848.